Sean Grant, CHIEF FINANCIAL OFFICER at Vera Therapeutics, Inc. (VERA), sold 4,949 shares at $41.98 ($208K) on 2026-02-23, disclosed to the SEC on 2026-02-25.
Open-market sale of $208k VERA by CHIEF FINANCIAL OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| VERA | BUY | 2023-02-17 | $100K | — | Filing → |
| VERA | BUY | 2023-02-08 | $100K | — | Filing → |
| VERA | BUY | 2022-06-16 | $68K | — | Filing → |